Support and Resources for Patients

If a healthcare provider has already determined that a Gilead treatment is right for a patient, then the Gilead Advancing Access® program is committed to helping them afford their medication every step of the way.

Financial Support

For patients who need assistance with their co-pays or paying for medication, Advancing Access is available to help match them to a program that best meets their financial needs based on their particular circumstances and insurance situation and the eligibility criteria for the programs.

Advancing Access is available to help patients:

  • Lower their co-pay* and find other co-pay support, if eligible
  • Find and get financial support if they have government insurance
  • Find and get financial support if they are uninsured

*See specific terms and conditions at www.GileadAdvancingAccess.com

Insurance Support

Advancing Access is available to help guide patients through the process of understanding the type of insurance they have and alternative coverage if needed.

Advancing Access is available to help patients:

  • Identify and confirm coverage and benefits
  • When their insurance or coverage changes
  • When they need assistance understanding insurance

Find out more about the Gilead Advancing Access program:

Enroll at GileadAdvancingAccess.com by downloading and completing the enrollment form today.

Call
Hours: Monday–Friday | 9 am to 8 pm ET

Important Safety Information

What is the most important information I should know about ATRIPLA®?

ATRIPLA may cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. ATRIPLA is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking ATRIPLA, your HBV may suddenly get worse. Do not stop taking ATRIPLA without first talking to your healthcare provider, as they will need to monitor your health.

WHAT IS ATRIPLA?

ATRIPLA is a prescription medication that can be used alone as a complete regimen, or in combination with other anti-HIV-1 medicines, to treat HIV-1 in patients who weigh at least 40 kg (88 lbs).

ATRIPLA does not cure HIV-1 infection or AIDS, and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections. You should remain under the care of a doctor when using ATRIPLA.

Please click here for full Prescribing Information, including Patient Information with important warnings.

CLICK TO EXPAND

Important Safety Information

What is the most important information I should know about ATRIPLA®?

ATRIPLA may cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. ATRIPLA is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking ATRIPLA, your HBV may suddenly get worse. Do not stop taking ATRIPLA without first talking to your healthcare provider, as they will need to monitor your health.